Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941–August 10, 2018
Salma K. Jabbour(Rutgers, The State University of New Jersey), Thomas J. FitzGerald(University of Massachusetts Chan Medical School), Theodore L. DeWeese(Johns Hopkins University), John C. Breneman(University of Cincinnati), Nadia Laack(Mayo Clinic), Joel M. Cherlow(Miller Children's & Women's Hospital), Torunn I. Yock(Massachusetts General Hospital), Sarah S. Donaldson(Stanford University), John A. Kalapurakal(Northwestern University), Lynn Million(VA Palo Alto Health Care System), Karen J. Marcus(Harvard University), Jeff M. Michalski(Washington University in St. Louis), Edward C. Halperin(University of Louisville), Malcolm A. Smith(National Cancer Institute), Kenneth B. Roberts(University of North Carolina at Chapel Hill), Robert B. Marcus(St. Jude Children's Research Hospital), Shannon M. MacDonald(Massachusetts General Hospital), Daniel J. Indelicato(University of Florida), Robert Timmerman(The University of Texas Southwestern Medical Center), Nancy P. Mendenhall(University of Florida Health), Stephanie A. Terezakis(Johns Hopkins University), Maryann Bishop‐Jodoin(Health Insurance Review and Assessment Service), Suzanne L. Wolden(Memorial Sloan Kettering Cancer Center), Natia Esiashvilli(Emory University), David Raben(St. Jude Children's Research Hospital), Lisa A. Kachnic(NewYork–Presbyterian Hospital), Bernadine Donahue(Maimonides Medical Center), Daphne A. Haas‐Kogan(Brigham and Women's Hospital), Nancy J. Tarbell(Harvard University), Carolyn Freeman(McGill University), Patrick Thomas(University of Massachusetts Chan Medical School), Fran Laurie(University of Massachusetts Chan Medical School), Stephanie M. Perkins(Baylor College of Medicine), Louis S. Constine(University of Rochester Medical Center)
International Journal of Radiation Oncology*Biology*Physics
March 13, 2019
Cited by 0
Related Papers
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k